Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and ...

Diabetes drug Mountjaro has been on the list since 2022 and weight-loss drug Zepbound was added in April. The shortage has forced consumers to turn to drug compounders, who make equivalent ...

We chose Coupons.com for our ranking because they offer free printable coupons, free digital coupons, and a mobile app that lets you earn automatic rewards on eligible purchases. With the Coupons ...

Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources ...

Joshua Cohen is a Boston-based writer who covers health policy. Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published ...

Boston-based online furniture and home goods company Wayfair was founded more than 20 years ago and has expanded since, currently offering 14 million items from more than 11 thousand global ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide ...

You’ll have to read the fine print of each coupon to see what qualifies. Most products, including most laptops, can be returned within 30 days of your order for a full refund. However ...

Now, Eli Lilly is looking to lower that cost a little. The company, which makes treatments like Mounjaro and Zepbound, just announced that it has launched single-dose vials of the latter.